Biogroup UK Revenue and Competitors
Estimated Revenue & Valuation
- Biogroup UK's estimated annual revenue is currently $630k per year.
- Biogroup UK's estimated revenue per employee is $70,000
Employee Data
- Biogroup UK has 9 Employees.
- Biogroup UK grew their employee count by -25% last year.
Biogroup UK's People
Name | Title | Email/Phone |
---|
Biogroup UK Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.2M | 22 | -52% | N/A | N/A |
#2 | $16.2M | 116 | -6% | N/A | N/A |
#3 | $18.3M | 131 | -4% | $68M | N/A |
#4 | $23.6M | 153 | 12% | N/A | N/A |
#5 | $76.7M | 438 | -1% | N/A | N/A |
#6 | $3.6M | 32 | -11% | N/A | N/A |
#7 | $4.6M | 41 | 5% | N/A | N/A |
#8 | $7.4M | 59 | -16% | N/A | N/A |
#9 | $0.6M | 18 | 0% | $23M | N/A |
#10 | $1.6M | 23 | -38% | $4.9M | N/A |
What Is Biogroup UK?
Biogroup, is one of Europe's leading biological testing and analysis laboratory groups. Founded in France in 1998, today Biogroup manages more than 20,000 patients every day and undertakes more than 2,000 daily routine and specialized examinations. In the UK, Biogroup is initially focused on providing more than 100,000 private COVID-19 tests a week, via its mega lab in Shepherds Bush. For more information please visit www.biogroup-laboratory.co.uk
keywords:N/AN/A
Total Funding
9
Number of Employees
$630k
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biogroup UK News
PanTheryx(APS BioGroup and La Belle, Inc), Colostrum BioTec, Immuno-Dynamics, Ingredia Nutritional, ... Europe (UK, Germany, France and the rest of Europe)
Cleaver Scientific, Helena Laboratories, Bio Group Medical System, BPC Biosed, ... Europe (UK, Germany, France and the rest of Europe)
... To Steal Growth Being Into A Frenzy Of Innovation|APS Biogroup, ... North America (the U.S., Canada, and Mexico), Europe (Germany, UK,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | -40% | N/A |
#2 | $0.2M | 9 | 13% | $500M |
#3 | $0.7M | 9 | -10% | N/A |
#4 | $0.6M | 9 | 0% | N/A |
#5 | $0.7M | 9 | -55% | N/A |